Trump Strikes Landmark Deal To Slash Obesity Drug Prices, A U-Turn That Could Upend Global Phar
In a move reverberating across global healthcare and financial markets, Donald Trump has announced a deal to cap insulin prices ...
In a move reverberating across global healthcare and financial markets, Donald Trump has announced a deal to cap insulin prices ...
Recently, a study published in The Lancet journal of medicine threw up shocking findings. More than half of all adults ...
Soft drinks, with their widespread availability and aggressive marketing, have become a significant contributor to the escalating obesity rates, especially ...
Some of this year’s best performers in the healthcare sector are companies expected to profit from the anti-obesity drug craze, ...
You would think a new class of high-price weight loss drugs taken by millions of Americans would be a problem ...
Amgen has a couple of shots on goal to break into one of the biggest markets the pharmaceutical industry has ...
MarketsHeard on the StreetThe decision to get into the business for drugs such as Ozempic makes sense
Chennai: A study released by the Hyderabad-based Council for Social Development using National Family Health Survey (NFHS) data found that ...